Owing to the inability of samples with immunohistochemical staining data obtained from the Human Protein Atlas database to accurately distinguish cancer grades, stage subtypes, and the corresponding number of samples, it was not possible to analyze the specific effects of the subcellular localization of CD24 on prognosis in large-scale clinical samples. Here, CD24 is linked to cancer.